| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/15/2003 | WO2003039245A2 Transgenic mice knockout for histamine receptor h3 gene |
| 05/15/2003 | WO2003039226A2 Front opening body armor |
| 05/15/2003 | WO2003039225A2 Antigen arrays comprising rankl for treatment of bone disease |
| 05/15/2003 | WO2003026397A3 Thyrotropin releasing hormone receptor disruptions, compositions and methods relating thereto |
| 05/15/2003 | WO2003025171A3 Modulation of retinoic acid receptor gene expression and therapeutic uses thereof |
| 05/15/2003 | WO2003020754A3 Inhibition of replication factor c |
| 05/15/2003 | WO2002097032A3 Proteins associated with cell growth, differentiation, and death |
| 05/15/2003 | WO2002090508A3 Cell adhesion-mediating proteins and polynucleotides encoding them |
| 05/15/2003 | WO2002088318A3 Lipid-comprising drug delivery complexes and methods for their production |
| 05/15/2003 | WO2002077277A3 Dna markers for assessing seed purity and a method of using dna sequences for assessing seed purity |
| 05/15/2003 | WO2002068637A8 Nucleic acid-based treatment of diseases or conditions related to west nile virus infection |
| 05/15/2003 | WO2002063003A3 Platlet glycoprotein ib alpha fusion polypeptides and methods of use thereof |
| 05/15/2003 | WO2002063001A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 05/15/2003 | WO2002059156A3 Therapeutic compounds structurally-linked to bacterial polypeptides |
| 05/15/2003 | WO2002057451A9 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein |
| 05/15/2003 | WO2002055728A3 Compositions and methods for regulating receptor clustering |
| 05/15/2003 | WO2002048366A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/15/2003 | WO2002048365A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/15/2003 | WO2002048364A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/15/2003 | WO2002040654A3 A human serpin secreted from lymphoid cells lsi-01 |
| 05/15/2003 | WO2002040533A1 Radiosensitivity enhancers in radiotherapy for cancer and nucleic acids and proteins enhancing radiosensitivity |
| 05/15/2003 | WO2002038606A3 Compositions and methods relating to ovary specific genes and proteins |
| 05/15/2003 | WO2002034034A8 Transgenic plants with reduced expression of endogenous phytochrome a, exhibiting improved rooting, and methods for their production |
| 05/15/2003 | WO2002029059A9 Nogo receptor homologs |
| 05/15/2003 | WO2002029031A3 Isoprenoid-dependent ras anchorage (idra) proteins |
| 05/15/2003 | WO2002029025A9 Factor vii glycoforms |
| 05/15/2003 | WO2002026987A3 A human g-protein coupled receptor, hgprbmy6, expressed highly in small intestine |
| 05/15/2003 | WO2002026981A3 Human protease inhibitor proteins and polynucleotides encoding the same |
| 05/15/2003 | WO2002026781A9 Ige receptor antagonists |
| 05/15/2003 | WO2002024913A3 32612, a novel human peptide transporter and uses therefor |
| 05/15/2003 | WO2002018424A3 Nucleic acids and polypeptides |
| 05/15/2003 | WO2002016600A3 Novel proteins and nucleic acids encoding same |
| 05/15/2003 | WO2002014348A3 Glycoproteins and methods of use thereof |
| 05/15/2003 | WO2002012475A3 C1q-related factor, homologous polypeptides and therapeutic uses thereof |
| 05/15/2003 | WO2002006448A3 Transformation systems for flavinogenic yeast |
| 05/15/2003 | WO2001071309A3 Methods and reagents for regulation of cellular responses in biological systems |
| 05/15/2003 | US20030093838 XRCC1 and uses thereof |
| 05/15/2003 | US20030093837 Polynucleotides for seed trait alteration |
| 05/15/2003 | US20030093835 Chimeric genes controlling flowering |
| 05/15/2003 | US20030093833 Stress tolerant plants |
| 05/15/2003 | US20030093830 Means for identifying the locus of a major resistance gene to the rice yellow mottle virus, and their applications |
| 05/15/2003 | US20030093828 Seed specific 7Salpha promoter for expressing genes in plants |
| 05/15/2003 | US20030093825 Putative neurotransmitter receptor (PNR) disruptions, compositions and methods relating thereto |
| 05/15/2003 | US20030093821 For therapy of human subject diagnosed for predisposition for increased serum cholesterol or LDL cholesterol |
| 05/15/2003 | US20030093819 Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereof |
| 05/15/2003 | US20030093818 Transgenic animals comprising a humanized immune system |
| 05/15/2003 | US20030092903 Nucleotide sequences coing polypeptide for use in the treatment, diagnosis and prevention of lymes's disease |
| 05/15/2003 | US20030092902 Fusion protein for use in the treatment body weight disorders |
| 05/15/2003 | US20030092900 Meth1 and Meth2 polynucleotides and polypeptides |
| 05/15/2003 | US20030092899 Polynucleotide functionally coding for the LHP protein from Mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same |
| 05/15/2003 | US20030092898 Nucleotide sequences coding polypeptide for use in diagnosis, monitoring, classification, imaging and treatment of mamary gland cancer |
| 05/15/2003 | US20030092897 Antigen composition against mycoplasma |
| 05/15/2003 | US20030092895 Human potassium channel 1 and 2 proteins |
| 05/15/2003 | US20030092894 Conjugated antigen for use as tool in the treatment of cancer |
| 05/15/2003 | US20030092893 Antibody for use in the diagnosis of cancer, reproductive, kidney and nervous system disorders |
| 05/15/2003 | US20030092891 Expressed ligand - vascular intercellular signalling molecule |
| 05/15/2003 | US20030092890 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/15/2003 | US20030092889 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/15/2003 | US20030092888 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/15/2003 | US20030092887 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/15/2003 | US20030092886 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of tumors and cell proliferative disorders |
| 05/15/2003 | US20030092885 Solubility and stability enhancement tag for structural and ligand binding studies of proteins |
| 05/15/2003 | US20030092884 Nucleotide sequences coding polypeptide for use in the as diagnostic tool in genetic analysis |
| 05/15/2003 | US20030092883 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer and nervous system disorders |
| 05/15/2003 | US20030092882 Host cells containing multiple integrating vectors |
| 05/15/2003 | US20030092881 Polypeptide for use in diagnosis and treatment of gastrointestinal disorders |
| 05/15/2003 | US20030092665 Methods and compositions for administering DNA to mucosal surfaces |
| 05/15/2003 | US20030092661 88kDa tumorigenic growth factor and antagonists |
| 05/15/2003 | US20030092657 PAX2 is a transcription factor; apoptosis activators or anticarcinogenic agents |
| 05/15/2003 | US20030092656 Therapeutic agents for treatment of solid tumors comprising an expression-inhibiting sustance against Wilms' tumor gene (WT1) |
| 05/15/2003 | US20030092653 Method for inhibition of pathogenic microorganisms |
| 05/15/2003 | US20030092645 Cloning, expression, viral and delivery vectors and hosts |
| 05/15/2003 | US20030092632 Sulfated CCR5 peptides for HIV-1 infection |
| 05/15/2003 | US20030092631 IGF antagonist peptides |
| 05/15/2003 | US20030092629 Inhibitors of memapsin 2 and use thereof |
| 05/15/2003 | US20030092626 Use in drug screening, diagnosis, prophylaxis and treatment of central dysfunction, inflammatory diseases, cardiovascular disorders, diabetes, immune system disorders or gastrointestinal disorders |
| 05/15/2003 | US20030092624 Denaturant (boiling and/or detergent) stable; various uses including de-aggregating and/or preventing aggregation of an aggregating protein such as beta-amyloid or prions, restoring enzyme activity, and immunization using fusion protein |
| 05/15/2003 | US20030092623 Inducing proliferation of endothelial cells; use of Bv8 antagonists to treat testicular cancer and hormone dependent tumors; Bv8 is a small protein originally isolated from the skin secretions of the frog Bombina variegata |
| 05/15/2003 | US20030092618 Polypeptides, their production and use |
| 05/15/2003 | US20030092617 Production of vascular endothelial cell growth factor and DNA enconding same |
| 05/15/2003 | US20030092616 STAT6 activation gene |
| 05/15/2003 | US20030092614 Protein isoform related to sideroflexin 1, named ADPI-41, Alzheimer's disease-Associated Protein Isoform (ADPI); vectors, host cells, antibodies, vaccines; use in the diagnosis, screening, treatment and prophylaxis of AD |
| 05/15/2003 | US20030092613 Alpha7 nicotinic receptor peptides as ligands for beta amyloid peptides |
| 05/15/2003 | US20030092611 Nucleic acids, proteins, and antibodies |
| 05/15/2003 | US20030092604 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 05/15/2003 | US20030092188 Placental protein 13 |
| 05/15/2003 | US20030092175 Polypeptide for use as pharmaceuticals or as antigens for preparing antibodies against preferential polypeptides |
| 05/15/2003 | US20030092164 Polypeptide use in the treatment of cell proliferative disorders |
| 05/15/2003 | US20030092160 Genetically engineered cell for use in the generation of vaccines against bacterial and viral infections |
| 05/15/2003 | US20030092159 Efficient purification of proteasomes from cells; immobilizing ubiquitin amino acid sequence to solid support, incubate with cell lysate, elute proteasome from solid support |
| 05/15/2003 | US20030092157 Compositions, screening systems and methods for modulating HDL cholesterol and triglyceride levels |
| 05/15/2003 | US20030092152 Extraction of enyme inhibitors from plants; prepare straction solution, incubate with plant material, grind plant tissue, recover enzyme inhibitors from solution |
| 05/15/2003 | US20030092151 Removal of kunitz, bowman-birk and carboxypeptidase inhibitors from plant extract; gnerate plant extract, heat, cool, remove denatured protein, filter the purified extract to remove the carboxypeptidase and bowman-birk inhibitors |
| 05/15/2003 | US20030092150 Method for controlling the yield and purity of proteinase inhibitor II during extraction |
| 05/15/2003 | US20030092148 Mammalian genes; related reagents |
| 05/15/2003 | US20030092147 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 05/15/2003 | US20030092146 Avian mago nashi gene |
| 05/15/2003 | US20030092134 Nucleic acid encoding 3'-5' exonuclease of bacteriophage RM 378 |
| 05/15/2003 | US20030092133 Interleukins-21 and 22 |
| 05/15/2003 | US20030092132 Fusion protein for use as diagnostic tool in genetic engineering |